RI-MUHC researchers take leadership role in a new national platform seeking outpatient treatments for COVID-19
The Government of Canada announces $10 million to create...
MUHC designated first provincial establishment for islet cell transplants for patients with type 1 diabetes
Non-invasive procedure allows patients to live without fear...
RI-MUHC study highlights the role of fat metabolism enzyme in aggressive prostate cancer
A fatty acid metabolism enzyme drives prostate cancer aggressiveness...
Taking opioids at home after surgery: More harms than benefits
A new study conducted at the RI-MUHC concludes that prescribing opioid analgesics at discharge after surgery does not reduce postoperative pain...
New study: Montreal researchers identify three drugs that could reduce mortality in severely ill COVID-19 patients
Researchers from the RI-MUHC and the McGill Genome Centre examine...
The RI-MUHC is first in Canada to adopt sentinel-free animal health monitoring
One of ten champion institutions in North America, the RI-MUHC has completely switched to a new program...
New study shows associations between air pollution and respiratory health in Canada
RI-MUHC researchers demonstrate that exposure to relatively low levels of air pollution in Canada is associated...
Type 1 diabetes: a combination therapy improves glucose control and performance of artificial pancreases
A publication in Nature Medicine by RI-MUHC researchers describes...
RI-MUHC leads study to identify a novel mechanism driving aggressive prostate cancer
This international research collaboration may lead to a shift in the clinical management of patients...
Improving the performance of rapid tests through clear instructions
Researchers at the RI-MUHC investigate whether rapid antigenic detection tests for COVID-19 could be adequately used in the workplace.